Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer_journal/two-immunomodulators-curcumin-and-sulfasalazine-enhance-idv-NXT73I068p
References (27)
-
H. Chai, Hui Yang, Shaoyu Yan, Min Li, P. Lin, A. Lumsden, Q. Yao, Changyi Chen (2005)
Effects of 5 HIV Protease Inhibitors on Vasomotor Function and Superoxide Anion Production in Porcine Coronary ArteriesJAIDS Journal of Acquired Immune Deficiency Syndromes, 40
-
T. Goud, N. Reddy, N. Swamy, Tejomoortula Ram, Y. Venkateswarlu (2003)
Anti-HIV active petrosins from the marine sponge Petrosia similis.Biological & pharmaceutical bulletin, 26 10
-
C. Wahl, S. Liptay, G. Adler, R. Schmid (1998)
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.The Journal of clinical investigation, 101 5
-
F. Denizot, R. Lang (1986)
Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.Journal of immunological methods, 89 2
-
M. Bouyac, Françoise Rey, M. Nascimbeni, M. Courcoul, Joséphine Sire, D. Blanc, François Clavel, R. Vigne, Bruno Spire (1997)
Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cellsJournal of Virology, 71
-
D. Gilden, T. Smart (1996)
Curcumin trial finds no activity.GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 10 2
-
Yuan-Yuan Wang, D. Ouyang, Hai Huang, H. Chan, Siu-cheung Tam, Yong-tang Zheng (2005)
Enhanced apoptotic action of trichosanthin in HIV-1 infected cells.Biochemical and biophysical research communications, 331 4
-
F. Habens, Natarajan Srinivasan, F. Oakley, D. Mann, A. Ganesan, G. Packham (2005)
Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activityApoptosis, 10
-
W. Jordan, C. Drew (1996)
Curcumin--a natural herb with anti-HIV activity.Journal of the National Medical Association, 88 6
-
H. Chai, Shaoyu Yan, P. Lin, A. Lumsden, Q. Yao, Changyi Chen (2005)
Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries.Journal of the American College of Surgeons, 200 6
-
M. Pinti, P. Biswas, L. Troiano, M. Nasi, R. Ferraresi, C. Mussini, J. Vecchiet, R. Espósito, R. Paganelli, A. Cossarizza (2003)
Different Sensitivity to Apoptosis in Cells of Monocytic or Lymphocytic Origin Chronically Infected with Human Immunodeficiency Virus Type-1Experimental Biology and Medicine, 228
-
S. Bengmark (2006)
Curcumin, An Atoxic Antioxidant and Natural NFκB, Cyclooxygenase-2, Lipooxygenase, and Inducible Nitric Oxide Synthase Inhibitor: A Shield Against Acute and Chronic Diseases.JPEN. Journal of parenteral and enteral nutrition, 30 1
-
L. Belmonte, P. Baré, M. Bracco, B. Ruibal-Ares (2003)
Reservoirs of HIV replication after successful combined antiretroviral treatment.Current medicinal chemistry, 10 4
-
J. Kovacs, V. Gill, S. Meshnick, H. Masur (2001)
New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.JAMA, 286 19
-
Ricky Sharma, A. Gescher, W. Steward (2005)
Curcumin: the story so far.European journal of cancer, 41 13
-
R. Cancio, R. Silvestri, R. Ragno, M. Artico, G. Martino, G. Regina, E. Crespan, S. Zanoli, U. Hübscher, S. Spadari, G. Maga (2005)
High Potency of Indolyl Aryl Sulfone Nonnucleoside Inhibitors towards Drug-Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutants Is Due to Selective Targeting of Different Mechanistic Forms of the EnzymeAntimicrobial Agents and Chemotherapy, 49
-
K. Vermeire, T. Bell, Heung-Jin Choi, Q. Jin, M. Samala, A. Sodoma, E. Clercq, D. Schols (2003)
The Anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor.Molecular pharmacology, 63 1
-
V. Pande, M. Ramos (2003)
Nuclear factor kappa B: a potential target for anti-HIV chemotherapy.Current medicinal chemistry, 10 16
-
L. Calza, R. Manfredi, F. Chiodo (2003)
Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management.International journal of antimicrobial agents, 22 2
-
CJ Briggs, DE Ott, LV Coren, S Oroszlan, J Tozser (1999)
Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1Arch Virol, 144
-
A. Bharti, N. Donato, Sujay Singh, B. Aggarwal (2003)
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosisBlood, 101
-
F Denizot, R Lang (1986)
Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliabilityJ Inmunol Methods, 89
-
A. Gaffo, K. Saag, J. Curtis (2006)
Treatment of rheumatoid arthritis.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 63 24
-
E. Strasser, B. Wessner, N. Manhart, E. Roth (2005)
The relationship between the anti-inflammatory effects of curcumin and cellular glutathione content in myelomonocytic cells.Biochemical pharmacology, 70 4
-
I. Ventoso, J. Navarro, M. Muñoz, Luis Carrasco (2005)
Involvement of HIV-1 protease in virus-induced cell killing.Antiviral research, 66 1
-
R. Essey, B. McDougall, W. Robinson (2001)
Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitro.Antiviral research, 51 3
-
J. Kimpton, M. Emerman (1992)
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase geneJournal of Virology, 66
- Publisher
- Springer Journals
- Copyright
- Copyright © 2008 by Springer-Verlag
- Subject
- Biomedicine; Infectious Diseases; Medical Microbiology ; Virology
- ISSN
- 0304-8608
- eISSN
- 1432-8798
- DOI
- 10.1007/s00705-007-0023-4
- pmid
- 18175040
- Publisher site
- See Article on Publisher Site
Abstract
Since the appearance of resistance to antiretroviral treatment is unavoidable, the host cell’s transcription factor NF-kappaB is a novel HIV target. The goal of this study was to characterize the effect of two immunomodulators, curcumin (Cur) and sulfasalazine (Sul), with a protease inhibitor, indinavir (IDV), on HIV-1 persistently infected CD4+ T-cells. Viral p24 antigen production, viral infectivity (tested on MAGI cells) and viral relative infectivity (viral infectivity/p24) were analysed. When used alone, both immunomodulators were able to reduce viral infectivity. When in combination, both 10 μM IDV plus 10 μM Cur and 10 μM IDV plus 250 μM Sul showed a significant reduction in viral infectivity and viral relative infectivity when compared to the reduction produced by IDV alone. Thus, the use of immunomodulators with IDV could help to reduce HIV-1 production in persistently infected cells.
Journal
Archives of Virology – Springer Journals
Published: Mar 1, 2008